EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Preemptive versus prophylactic therapy using valganciclovir or ganciclovir in renal transplant recipients for the prevention of cytomegalovirus infection: a systematic review and meta-analysis

Michelle Wendy Te, Carlo Boado, Larraine Vergara-Rejante, Ethan Elijah Suarez

Clinical Transplantation and Research · 2023

DOI: 10.4285/atw2023.f-8170 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Transplantation and Research, 2023. Verfasst von Michelle Wendy Te und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Kidney transplant recipients are at risk for developing cytomegalovirus (CMV) disease and subsequently, allograft rejection and graft loss. The current practice of prophylaxis with antiviral therapy in the early posttransplant period for high risk patients is costly. Preemptive therapy involves a protocol of routine testing for CMV viral load, and treatment is initiated for positive patients. It is unknown if preemptive therapy is an effective strategy to prevent CMV disease. This study aims to assess the efficacy of preemptive versus prophylactic therapy with valganciclovir or ganciclovir in preventing CMV disease in kidney transplant recipients.

Methods

A comprehensive search of PubMed/Medline, Cochrane, and Google scholar was performed to identify clinical trials on the efficacy of preemptive versus prophylactic valganciclovir or ganciclovir in preventing CMV disease. The primary outcome is development of CMV infection. Secondary outcomes include acute allograft rejection, allograft loss, and mortality.

Zitieren

APA

Te, M. W., Boado, C., Vergara-Rejante, L., & Suarez, E. E. (2023). Preemptive versus prophylactic therapy using valganciclovir or ganciclovir in renal transplant recipients for the prevention of cytomegalovirus infection: a systematic review and meta-analysis. Clinical Transplantation and Research. https://doi.org/10.4285/atw2023.f-8170

Vancouver

Te MW, Boado C, Vergara-Rejante L, Suarez EE. Preemptive versus prophylactic therapy using valganciclovir or ganciclovir in renal transplant recipients for the prevention of cytomegalovirus infection: a systematic review and meta-analysis. Clinical Transplantation and Research. 2023. doi:10.4285/atw2023.f-8170

BibTeX
@article{Te2023,
  author = {Te, Michelle Wendy and Boado, Carlo and Vergara-Rejante, Larraine and Suarez, Ethan Elijah},
  title = {Preemptive versus prophylactic therapy using valganciclovir or ganciclovir in renal transplant recipients for the prevention of cytomegalovirus infection: a systematic review and meta-analysis},
  journal = {Clinical Transplantation and Research},
  year = {2023},
  doi = {10.4285/atw2023.f-8170}
}
Kostenlos starten →